Tu CL, Chang W, Bikle DD: The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes.
J Biol Chem 2001, 276:41079–41085.
Smit LH, Korse CM, Hart AA, Bonfrer JM, Haanen JB, Kerst JM, Nieweg OE, de Gast GC: Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.
Eur J Cancer 2005, 41:386–392.
Donato R: Intracellular and extracellular roles of S100 proteins.
Microsc Res Tech 2003, 60:540–551.
Jackel A, Deichmann M, Waldmann V, Bock M, Näher H: S-100β protein in serum, a tumor marker in malignant melanoma--current state of knowledge and clinical experience.
Hautarzt 1999, 50:250–256.
Lippi G, Aloe R, Numeroso F, Cervellin G: The significance of protein S-100B testing in cardiac arrest patients.
Clin Biochem 2011, 44:567–575.
Portela LV, Brenol JC, Walz R, Bianchin M, Tort AB, Canabarro UP, Beheregaray S, Marasca JA, Xavier RM, Neto EC, Gonçalves CA, Souza DO: Serum S100B levels in patients with lupus erythematosus: preliminary observation.
Clin Diagn Lab Immunol 2002, 9:164–166.
Schenatto CB, Xavier RM, Bredemeier M, Portela LV, Tort AB, Dedavid e Silva TL, Souza DO, Brenol JC: Raised serum S100B protein levels in neuropsychiatric lupus.
Ann Rheum Dis 2006, 65:829–831.
Bartosik-Psujek H, Psujek M, Jaworski J, Stelmasiak Z: Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone.
Acta Neurol Scand 2011, 123:252–256.
Cohly HH, Panja A: Immunological findings in autism.
Int Rev Neurobiol 2005, 71:317–341.
Vojdani A, Pangborn JB, Vojdani E, Cooper EL: Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major investigators of autoimmunity in autism.
Int J Immunopathol Pharmacol 2003, 16:189–199.
Singh VK, Warren RP, Odell JD, Warren WL, Cole P: Antibodies to myelin basic protein in children with autistic behavior.
Brain Behav Immun 1993, 7:97–103.
Mostafa GA, Al-Ayadhi LY: A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children.
J Neuroinflammation 2011, 8:71.
Singh VK, Lin SX, Yang VC: Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism.
Clin Immunol Immunopathol 1998, 89:105–108.
Singh VK, Warren RP, Averett R, Ghaziuddin M: Circulating autoantibodies to neuronal and glial filament proteins in autism.
Pediatr Neurol 1997, 17:88–90.
Singh VK, Rivas WH: Prevalence of serum antibodies to caudate nucleus in autistic children.
Neurosci Lett 2004, 355:53–56.
Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF: Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children.
J Child Neurol 2008, 23:1413–1418.
Mostafa GA, Al-Ayadhi LY: Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.
J Neuroinflammation 2011, 8:39.
Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN: Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism.
J Child Neurol 1999, 14:388–394.
Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ: Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders.
Pediatrics 2003, 112:420–424.
Mostafa GA, Kitchener N: Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children.
Pediatr Neurol 2009, 40:107–112.
Mostafa GA, Shehab A: The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children.
J Neuroimmunol 2010, 223:115–119.
Crespi BJ, Thiselton DL: Comparative immunogenetics of autism and schizophrenia.
Genes Brain Behav 2011, 10:689–701.
Mostafa GA, Al Shehab A, Fouad NR: Frequency of CD4
regulatory T cells in the peripheral blood of Egyptian children with autism.
J Child Neurol 2010, 25:328–335.
Warren RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL, White E: Increased frequency of the null allele at the complement C4b locus in autism.
Clin Exp Immunol 1991, 83:438–440.
Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H, Stubbs G, Henley K, Torres A: Confirmation of the association of C4B null allele in autism.
Hum Immunol 2005, 66:140–145.
Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH: Auto-antibodies in neuropsychiatric lupus.
Autoimmunity 2002, 35:79–86.
Gerli R, Caponi L: Anti-ribosomal P protein antibodies.
Autoimmunity 2005, 38:85–92.
Toubi E, Shoenfeld Y: Clinical and biological aspects of anti-P-ribosomal protein autoantibodies.
Autoimmun Rev 2007, 3:119–125.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
Schopler E, Reichler RJ, Renner BR: The Childhood Autism Rating Scale (CARS) for Diagnostic Screening and Classification of Autism. New York: Irvington; 1986.
Green AJ, Keir G, Thompson EJ: A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid.
J Immunol Methods 1997, 205:35–41.
Quincozes-Santos A, Abib RT, Leite MC, Bobermin D, Bambini-Junior V, Gonçalves CA, Riesgo R, Gottfried C: Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells.
Mol Cell Biochem 2008, 314:59–63.
Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg MR, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D: Peripheral markers of brain damage and blood-brain barrier dysfunction.
Restor Neurol Neurosci 2003, 21:109–121.
Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, Stöcklein V, Bazarian JJ: Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
J Neurotrauma 2009, 26:1497–1507.
Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, Hoecherl EF, Jonas F, Marzi I, Leucht P, Jochum M, Mutschler W: Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury: a prospective multicenter study.
Shock 2006, 25:446–453.
Rothermundt M, Ponath G, Arolt V: S100B in schizophrenic psychosis.
Int Rev Neurobiol 2004, 59:445–470.
Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.
Stroke 1997, 28:1956–1960.
Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Proc Natl Acad Sci USA 1989, 86:7611–7615.
Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B: Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome.
Neurosurgery 1999, 45:468–475.
Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, Gippner-Steppert C, Jochum M: Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma.
World J Surg 2001, 25:93–97.
Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW: Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury.
Restor Neurol Neurosci 1999, 14:109–114.
Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG: Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.
Stroke 1991, 22:1254–1258.
Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, Stevens GH, Masaryk T, Aumayr B, Vogelbaum MA, Barnett GH, Janigro D: Serum S100β: a noninvasive marker of blood-brain barrier function and brain lesions.
Cancer 2003, 97:2806–2813.
Ruan S, Noyes K, Bazarian JJ: The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury.
J Neurotrauma 2009, 26:1655–1664.
Gonçalves CA, Leite MC, Nardin P: Biological and methodological features of the measurement of S100B, a putative marker of brain injury.
Clin Biochem 2008, 41:755–763.
Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.
Int J Biochem Cell Biol 2001, 33:637–668.
Yano J, Lilly E, Barousse M, Fidel PL Jr: Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during
Infect Immun 2010, 78:5126–5137.
Beer C, Blacker D, Bynevelt M, Hankey GJ, Puddey IB: Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke.
J Neuroinflammation 2010, 29:7–71.
Schmidt S: S100B: pathogenetic and pathophysiologic significance in neurology.
Nervenarzt 1998, 69:639–646.
Massaro AR, Michetti F, Laudisio A, Bergonzi P: Myelin basic protein and S-100 antigen in cerebrospinal fluid of patients with multiple sclerosis in the acute phase.
Ital J Neurol Sci 1985, 6:53–56.
Michetti F, Massaro A, Russo G, Rigon G: The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system.
J Neurol Sci 1980, 44:259–263.
Yang XY, Lin J, Lu XY: Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus.
Clin Rheumatol 2008, 27:353–357.
Al-Ayadhi LY, Mostafa GA: Increased serum osteopontin levels in autistic children: relation to the disease severity.
Brain Behav Immun 2011, 25:1393–1398.
Al-Ayadhi LY, Mostafa GA: Low plasma progranulin levels in children with autism.
J Neuroinflammation 2011, 8:111.
Enstrom AM, Van de Water JA, Ashwood P: Autoimmunity in autism.
Curr Opin Investig Drugs 2009, 10:463–473.
Mostafa GA, Al-Ayadhi LY: The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.
J Neuroinflammation 2011, 8:180.
Ben-Ami SD, Blank M, Altman A: The clinical importance of anti-ribosomal-P antibodies.
Harefuah 2010, 149:794–797.
Mostafa GA, Ibrahim DH, Shehab AA, Mohammed AK: The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus.
J Neuroimmunol 2010, 227:195–201.
Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, Zhang W, Reichlin M, Shoenfeld Y: Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.
Arthritis Rheum 2007, 56:938–948.
Sheikh Z, Ahmad R, Sheikh N, Ali R: Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies.
Autoimmunity 2007, 40:512–520.
Wang G, König R, Ansari GA, Khan MF: Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4
Free Radic Biol Med 2008, 44:1475–1482.
Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM: Oxidative stress in Egyptian children with autism: relation to autoimmunity.
J Neuroimmunol 2010, 219:114–118.
Javeed A, Zhao Y: The effects of immunosuppression on regulatory CD4
T cells: impact on immunosuppression selection in transplantation.
Mol Diagn Ther 2008, 12:171–181.
Vignali DA, Collison LW, Workman CJ: How regulatory T cells work.
Nat Rev Immunol 2008, 8:523–532.